33 related articles for article (PubMed ID: 7448398)
1. [Dihydrotachysterol treatment in children with chronic renal failure].
Sieniawska M; Tolloczko I
Pol Tyg Lek; 1977 Jan; 32(5):181-4. PubMed ID: 834657
[No Abstract] [Full Text] [Related]
2. Therapy of renal osteodystrophy with dihydrotachysterol in non-dialyzed patients.
Teredesai P; Winaver J; Martin LG; Cranley R; Conner TB; Hartsock RJ; Puschett JB
Clin Nephrol; 1980 Jan; 13(1):31-9. PubMed ID: 7363513
[TBL] [Abstract][Full Text] [Related]
3. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
[No Abstract] [Full Text] [Related]
4. Effect of treatment with dihydrotachysterol on renal function in patients with chronic renal failure.
Cordy PE; Hodsman AB
Miner Electrolyte Metab; 1984; 10(5):281-5. PubMed ID: 6493156
[TBL] [Abstract][Full Text] [Related]
5. Can renal bone disease be prevented?
Shaldon S
Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
[No Abstract] [Full Text] [Related]
6. [Effect of dihydrotachysterol on bone tissue in rats with experimental kidney failure].
Iagodovskiĭ VS; Ermolenko VM; Spirichev VB; Blazheevich NV; Migunova NA
Biull Eksp Biol Med; 1980 Nov; 90(11):611-3. PubMed ID: 7448398
[TBL] [Abstract][Full Text] [Related]
7. Renal osteodystrophy.
Teitelbaum SL
Hum Pathol; 1984 Apr; 15(4):306-23. PubMed ID: 6370824
[No Abstract] [Full Text] [Related]
8. Bone histomorphometry in renal osteodystrophy.
Ott SM
Semin Nephrol; 2009 Mar; 29(2):122-32. PubMed ID: 19371803
[TBL] [Abstract][Full Text] [Related]
9. A structural approach to renal bone disease.
Parfitt AM
J Bone Miner Res; 1998 Aug; 13(8):1213-20. PubMed ID: 9718188
[No Abstract] [Full Text] [Related]
10. Uremic bone disease: current knowledge, controversial issues, and new horizons.
Malluche HH; Monier-Faugere MC
Miner Electrolyte Metab; 1991; 17(4):281-96. PubMed ID: 1813791
[TBL] [Abstract][Full Text] [Related]
11. Renal osteodystrophy for nonnephrologists.
Goodman WG
J Bone Miner Metab; 2006; 24(2):161-3. PubMed ID: 16502125
[No Abstract] [Full Text] [Related]
12. The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol, and calcifediol.
Voigts AL; Felsenfeld AJ; Llach F
Arch Intern Med; 1983 May; 143(5):960-3. PubMed ID: 6089682
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
